How much does GILENYA (Fingolimod Hydrochloride Capsules) Cost& price without insurance in China?
GILENYA® is the commercial brand name of Fingolimod Hydrochloride Capsules, an orally active sphingosine‑1‑phosphate (S1P) receptor modulator developed by Novartis. It binds to S1P receptors on lymphocytes to retain immune cells in lymph nodes and block their infiltration into the central nervous system, thereby suppressing autoimmune inflammatory damage in multiple sclerosis.
Main Indications
Treatment of adult patients with relapsing multiple sclerosis (RMS), including clinically isolated syndrome, relapsing‑remitting multiple sclerosis and active secondary progressive multiple sclerosis.
Common Side Effects
Common mild adverse reactions: Bradycardia at initial administration, upper respiratory tract infection, headache, diarrhea, fatigue, elevated liver enzymes and cough.
Laboratory abnormalities: Peripheral lymphopenia, increased hepatic transaminases.
Severe but manageable risks: First‑dose bradycardia/atrioventricular block, severe opportunistic infections, macular edema and hepatotoxicity.
Approval Status in China
GILENYA® (Fingolimod Hydrochloride Capsules, 0.5mg, domestic trade name: Jielinya) was officially approved for marketing in China in 2019. It is currently a prescription drug included in China’s Category B medical insurance.
Buy GILENYA (Fingolimod Hydrochloride Capsules) online from China and save up to 80% on costs . no insurance needed . compare prices from a certified HongKong pharmacy .with fast shipping. Contact us now on WhatsApp to get the latest prices.
